Schizophrenia
|
| List Price: | CDN$ 258.99 |
| Price: | CDN$ 207.19 & eligible for FREE Super Saver Shipping on orders over $39. Details |
Availability: Usually ships in 2 to 4 weeks
Ships from and sold by Amazon.ca
8 new or used available from CDN$ 25.99
Average customer review:(1 )
Product Description
Schizophrenia is one of the most complex and puzzling diseases to affect mankind. It is the most common of the severe mental illnesses (psychoses) with an estimated prevalence of 0.5 - 1% in the general population and accounts for a very large portion of the day to day workload of the average psychiatrist. 50% of long-term psychiatric patients in mental hospitals are schizophrenic.
There is a great deal of controversy about the causes, diagnosis and treatment of schizophrenia with the consequence that a huge amount of research is carried out in the field by psychiatrists, psychologists, neuroscientists and pharmacologists. For the average practising psychiatrist seeing schizophrenics on a regular basis, making sense of the vast body of information on the subject and filtering out what is of clinical relevance can be very difficult. There is a constant stream of new drugs emerging and the newer generation of drugs (the so-called atypicals) is very effective, but often expensive.
The Editors (one American and one British) are both highly respected clinical psychiatrists who are probably the leading experts on schizophrenia from their respective countries and jointly have published almost 150 papers on the subject.
They have brought together a strong group of contributors from the USA, UK and Europe to produce what will be an essential reference for the trainee and practising psychiatrist.
The book consists of four sections; descriptive aspects, causative aspects, physical treatments and psychological/behavioural/social treatments. There will be discussion of the theoretical controversies over symptomatology, classification and aetiology, the relationship of schizophrenia to the other psychoses, the significance of positive and negative symptoms and pre-morbid personality. There will be chapters on organic models of schiziophrenia, neurodevelopmental, genetic and structural studies and the role of high-expressed emotion. The final section will cover social and environmental treatment, the role of the families of schizophrenics and the psychoanalytical therapies. There is a new chapter on the patient's perspective written by a former patient.
Product Details
- Amazon Sales Rank: #1568035 in Books
- Published on: 2003-02-03
- Original language: English
- Dimensions: 4.69 pounds
- Binding: Hardcover
- 768 pages
Editorial Reviews
Review
Critical acclaim for the first edition
"...well-edited book could serve as a textbook for a course or a reference book for clinicians and researchers. It is a comprehensive update of knowledge...an mpressive index..."
New England Journal of Medicine
"...an excellent book drawing together a vast range of knowledge...it ought to be on the shelves of any jobbing psychiatrists..."
Psychological Medicine
"...an admirable source of authoritative yet judicious opinions...inexpensive gem."
British Journal of Psychiatry
Book Info
West London Mental Health NHS Trust, UK. Text provides an updated, comprehensive account on the causes of schizophrenia, its biological, social and psychological elements, and its treatment and management. Includes new material on the neuropathy of schizophrenia, the dopamine theory, and the economics of the disorder. Previous edition: c1995.
From the Back Cover
There is a great deal of controversy surrounding the causes, diagnosis and treatment of schizophrenia with the consequence that a huge amount of research is carried out in the field by psychiatrists, psychologists, neuroscientists and pharmacologists.
Schizophrenia is an essential reference for psychiatrists in training and practice. The second edition of this highly successful book provides a factual account of current knowledge, evidence for its diagnostic validity and treatment and a summary of the disease’s pathophysiology. Reference to the latest brain imaging techniques and conceptualisation drawn from cognitive neuroscience will be provided where these are relevant, as will the description of newer anti-psychotic agents. Several new chapters have been included in this edition including one of the patient’s perspective written by a former patient.
